Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global Molecular Diagnostics Bundle on Cancer Testing, Genetic Testing, Infectious Disease Testing & MD Markets


News provided by

Research and Markets

11 Feb, 2016, 06:13 GMT

Share this article

Share toX

Share this article

Share toX

This image opens in the lightbox
Research and Markets Logo. (PRNewsFoto/PR NEWSWIRE EUROPE)

DUBLIN, February 11, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/rp4pg8/molecular) has announced the addition of the "Molecular Diagnostics Reports Bundle" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )


The Molecular Diagnostics Reports Bundle includes the following publications at a 15% discount off the individual reports being purchased separately:

- Molecular Diagnostics in Cancer Testing
- Molecular Diagnostics in Genetic Testing
- Molecular Diagnostics in Infectious Disease Testing
- Molecular Diagnostics Markets

Below are summaries of each report as well as links to purchase the individual titles.

'Molecular Diagnostics in Cancer Testing' (2015)

Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umbrella of molecular diagnostics include first-generation amplification, DNA probes, fluorescent in-situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors and molecular labels, and gene expression profiling using microarrays. These technologies are improving the discovery of therapeutic molecules for cancer, the screening, diagnosis and classification of cancer patients, and the optimization of drug therapy. 'Molecular Diagnostics in Genetic Testing' (2013)

Molecular diagnostics in genetic testing brings advanced analytical techniques to the diagnosis and treatment of genetic disorders. The confluence of breakthroughs in genomics and proteomics and the development of microarray devices to measure analytes in the blood and various body tissues are driving significant growth in the segment. Major developments include the integration of specialty labs and gene expression profiling into clinical practice, the introduction and rapid growth of cell-free fetal DNA prenatal testing, the advancement of companion diagnostics for drug development, the widespread installed base of automated instruments for molecular testing and the development of personalized medicine.

'Molecular Diagnostics in Infectious Disease Testing' (2015)

This report describes the specific segment of the in vitro diagnostics market known as molecular diagnostics testing for infectious disease. In the current medical diagnostics market, molecular diagnostics in infectious disease testing offers one of the most promising areas for growth and innovation. The confluence of breakthroughs in genomics and proteomics--along with the development of microarray devices to measure analytes in the blood--has led to this revolutionary market development. Specifically, molecular diagnostics offers the power of advanced analytical techniques to diagnose infectious diseases. Whereas before, the detection of many infectious agents was slow and expensive due to reliance upon culturing methods, researchers are now at the cusp of overcoming such limitations via the use of nucleic acid-mediated molecular diagnostics testing.

'Molecular Diagnostics Markets' (2013)

The technologies that constitute molecular diagnostics--like first-generation amplification, DNA probes, fluorescent in situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors, and molecular labels--are influencing the discovery of therapeutic molecules, the screening and diagnosis of patients, and the optimization of drug therapy. In the past few years, this rapidly evolving field has seen several fascinating developments. This report describes the specific market segment of the in vitro diagnostics market known as molecular diagnostics and includes all of the generally accepted clinical analytical activities in use today. It examines the prevalent clinical-measurement devices, as well as their reagents and supplies as utilized in hospitals, clinics, large reference laboratories and doctor's offices.

Key Topics Covered:

Table of Contents - Molecular Diagnostics in Cancer Testing

1. Overview

2. Introduction to Molecular Diagnostics

3. Cancer Diagnostics Molecular Testing Market

4. Molecular Diagnostic Tests for Cancer

5. Business

6. Reimbursement and Billing

7. Government Regulation

8. Business Decisions Using Molecular Diagnostic Tests in Drug Development

9. Company Profiles

Table of Contents - Molecular Diagnostics in Genetic Testing

1. Overview

2. Role of Molecular Diagnostics and Opportunities in the Genetic Testing Sector

3. Introduction to Molecular Diagnostics Technology for Genetic Testing

4. Business Landscape for Molecular Diagnostics in Genetic Testing

5. Molecular Diagnostic Assays and Select Laboratories for Genetic Testing on the Market

6. Reimbursement and Billing Landscape for Molecular Diagnostic Genetic Testing

7. Regulatory Issues for Genetic Testing

8. Business Decisions, Strategic Outlook and Recommendations Using Molecular Diagnostic Tests in Genetic Testing

9. Company Profiles

Table of Contents - Molecular Diagnostics in Infectious Disease Testing

1. Overview

2. Introduction to Molecular Diagnostics for Infectious Disease Testing

3. Infectious Disease Diagnostics Molecular Testing Market

4. Molecular Diagnostic Testing Technology for Infectious Disease Testing

5. Business

6. Reimbursement and Billing Landscape for Molecular Diagnostics Testing for Infectious Disease

7. Regulatory Requirements

8. Business Decisions using Molecular Diagnostic Tests in Infectious Disease Testing

9. Economics of Anti-Microbial Drug Resistance: The Persistent Need for Antibacterials

10. Company Profiles

Table of Contents - Molecular Diagnostics Markets

1. Overview

2. Introduction to Molecular Diagnostics and PCR Technology

3. Nucleic Acid Test Applications

4. Trends in Molecular Diagnostics

5. Molecular Diagnostics Automated Instrumentation Approved for Market by the FDA

6. Market Trends and Forecasts

7. Company Profiles

8. Market Overview

Companies Mentioned

- ARCA biopharma
- Abbott Laboratories
- Adnavance Technologies, Inc.
- AdvanDx
- Agendia
- Agilent Technologies
- Ambry Genetics
- American Diagnostica
- Applied Biosystems, Inc. (now Life Technologies)
- ArcticDx, Inc.
- Arcxis Biotechnologies
- Asuragen
- Atlas Genetics
- Aureon Laboratories
- AutoGenomics, Inc
- BG Medicine
- Beckman Coulter
- Becton, Dickinson and Company
- bioMerieux
- bioTheranostics
- Bio-Rad Laboratories
- BioGenex Laboratories, Inc
- BioHelix Corporation
- Biocartis
- Biotage AB
- Biotest AG
- Caliper Life Sciences, Inc.
- Celera
- Cepheid
- Clarient, Inc.
- CombiMatrix Corporation
- CytoCore, Inc.
- Cytocell Technologies Ltd.
- DiagnoCure, Inc.
- DxS
- EXACT Sciences Corporation
- EntroGen, Inc
- Enzo Biochem
- Epigenomics
- EraGen Biosciences
- Eurogentec
- Exact Sciences Corporation
- Exagen Diagnostics, Inc.
- Exiqon A/S
- Ferrer inCode
- Gen-Probe
- GenMark Diagnostics, Inc.
- Gene Express
- GeneOhm Sciences
- Genera Biosystems
- Genmark Diagnostics, Inc
- Genomic Health, Inc.
- Genomica
- Genomix Biotech
- Genoptix, Inc.
- Genzyme Corporation
- Great Basin Scientific
- Hologic, Inc
- Illumina, Inc
- Innogenetics NV
- IntegenX
- InterGenetics, Inc.
- Inverness Medical Innovations
- Invitrogen (Life Technologies)
- LabCorp
- Laboratory Corporation of America Holdings
- Life Technologies Corporation
- Luminex
- Luminex Corporation
- Mobidiag
- Monogram Biosciences, Inc.
- Myconostica
- Myriad Genetics, Inc
- Nanogen
- Nanosphere
- Natera
- NetBio
- NorDiag ASA
- Nuvera Biosciences
- Orion Genomics
- PANTHER System
- PerkinElmer Genetics
- PharMingen
- Progenika, Inc
- QIAGEN NV
- Roche Ltd
- Rosetta Genomics Ltd.
- SABiosciences Corporation
- SIRS-Lab
- Seegene
- Sequenom, Inc.
- Siemens Healthcare Diagnostics (Siemens)
- Signature Genomics
- Source MDx
- Spartan Bioscience, Inc
- Targeted Molecular Diagnostics
- Thermo Fisher Scientific
- Thorne Diagnostics
- Transgenomic, Inc
- TrimGen
- TrovaGene
- U.S. Genomics, Inc.
- Veredus Laboratories
- Veridex
- Xenomics, Inc.

For more information visit http://www.researchandmarkets.com/research/rp4pg8/molecular

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Laura Wood
+353-1-481-1716
press@researchandmarkets.net

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.